This report assesses the risk of invasive pulmonary aspergillosis (IPA) among patients with severe influenza in hospital intensive care units in the European Union (EU)/European Economic Area (EEA)
In early October, nine cases of autochthonous dengue were confirmed in the EU, three in Spain and six in France, in three separate outbreaks. These are the first autochthonous dengue cases in continental EU/EEA Member States that were reported this year.
As of 30 August 2018, Algeria has reported 74 confirmed cholera cases from six northern and coastal areas of the country. This is the first cholera outbreak reported in Algeria in more than 20 years.
This rapid risk assessment addresses the public health risk associated with the early occurrence of a large number of West Nile virus infections in the EU/EEA and EU neighbouring countries in 2018.
This update of the risk assessment published on 16 April 2018 was triggered by the unusual size and duration of the current dengue fever outbreak driven by Ae. albopictus, a mosquito vector present in Réunion and widely distributed in the southern part of EU.
Following the occurrence of several hospital-acquired malaria cases in the European Union (EU), ECDC has assessed the risk related to transmission of the parasite in hospital settings.
A dengue outbreak of unusual magnitude is currently taking place in the French Outermost Region of Réunion. Aedes albopictus mosquitoes are considered to be the principal vector. Dengue virus (DENV) transmission in Réunion is not unexpected.
In September 2017, the Ministry of Health in Brazil declared the end of the 2016–2017 yellow fever outbreak in the country. The upsurge of human cases since December 2017 and the continuous non-human primate epizootics since September 2017 indicate a continued or resumed increase in yellow fever virus circulation in Brazil. Since January 2018, most of the yellow fever cases have been reported from São Paulo, Rio de Janeiro and Minas Gerais states.